bf/NASDAQ:AKYA_icon.png

COM:AKOYABIO

Akoya Biosciences, Inc.

  • Stock

USD

Last Close

2.12

22/11 21:00

Market Cap

102.72M

Beta: -

Volume Today

81.11K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
4.18M
-
6.64M
58.89%
11.75M
77.00%
16.18M
37.71%
average payables
6.60M
-
14.14M
114.30%
25.17M
78.07%
19.46M
22.69%
average receivables
9.82M
-
7.96M
18.96%
9.59M
20.48%
13.36M
39.38%
book value per share
-1.04
-
0.64
161.58%
4.51
602.50%
1.55
65.60%
0.00
99.92%
capex per share
-0.10
-
-0.11
14.85%
-0.19
66.20%
-0.19
2.95%
-0.00
99.96%
capex to depreciation
-0.94
-
-0.86
8.03%
-1.06
23.08%
-1.03
3.15%
-0.41
60.09%
capex to operating cash flow
0.21
-
0.48
131.21%
0.14
70.67%
0.14
2.59%
0.07
47.83%
capex to revenue
-0.07
-
-0.08
14.29%
-0.09
19.48%
-0.10
5.99%
-0.04
61.55%
cash per share
0.75
-
0.59
21.48%
4.20
614.85%
2.15
48.82%
0.00
99.91%
days of inventory on hand
85.01
-
94.10
10.69%
158.95
68.91%
168.02
5.71%
161.80
3.70%
days payables outstanding
168.64
-
112.01
33.58%
409.07
265.22%
314.87
23.03%
106.58
66.15%
days sales outstanding
113.79
-
55.64
51.10%
62.77
12.81%
47.44
24.43%
64.19
35.32%
debt to assets
0.28
-
0.45
62.78%
0.17
61.94%
0.43
151.01%
0.48
10.37%
debt to equity
-0.82
-
1.88
329.61%
0.27
85.68%
1.29
379.45%
1.59
23.21%
dividend yield
0.00
-
earnings yield
-0.03
-
-0.03
13.25%
-0.10
260.94%
-0.20
87.56%
-0.00
99.85%
enterprise value
591.44M
-
596.31M
0.82%
331.18M
44.46%
362.79M
9.54%
216.84B
59,670.53%
enterprise value over ebitda
-54.65
-
-78.07
42.85%
-10.06
87.11%
-6.11
39.24%
-3.39K
55,261.71%
ev to operating cash flow
-42.93
-
-87.14
102.97%
-9.18
89.46%
-6.78
26.14%
-4.26K
62,720.18%
ev to sales
14.00
-
14.05
0.33%
6.03
57.08%
4.85
19.64%
2.24K
46,202.63%
free cash flow per share
-0.58
-
-0.35
39.09%
-1.53
336.50%
-1.61
5.35%
-0.00
99.92%
free cash flow yield
-0.03
-
-0.02
39.09%
-0.10
470.21%
-0.17
68.54%
-0.00
99.85%
graham net net
-2.97
-
-1.21
59.18%
2.05
268.81%
-0.57
128.05%
-0.00
99.91%
graham number
3.46
-
2.89
16.49%
12.73
340.57%
8.08
36.50%
0.01
99.92%
income quality
0.93
-
0.41
56.14%
0.84
105.09%
0.76
9.85%
0.80
6.14%
intangibles to total assets
0.47
-
0.53
11.27%
0.21
60.87%
0.22
5.42%
0.20
9.12%
interest coverage
-7.18
-
-4.22
41.21%
-11.95
183.16%
-14.54
21.66%
6.58
145.28%
interest debt per share
0.92
-
1.30
41.62%
1.33
2.21%
2.13
59.65%
0.00
99.92%
inventory turnover
4.29
-
3.88
9.66%
2.30
40.80%
2.17
5.40%
2.26
3.84%
invested capital
-0.82
-
1.88
329.61%
0.27
85.68%
1.29
379.45%
1.59
23.21%
market cap
578.32M
-
578.32M
0%
411.79M
28.80%
361.24M
12.28%
216.84B
59,927.11%
net current asset value
-78.70M
-
-30.39M
61.38%
71.26M
334.46%
-5.25M
107.37%
-4.81M
8.45%
net debt to ebitda
-1.21
-
-2.36
94.33%
2.45
204.01%
-0.03
101.07%
-0.04
53.74%
net income per share
-0.51
-
-0.58
13.25%
-1.60
176.30%
-1.87
17.24%
-0.00
99.92%
operating cash flow per share
-0.48
-
-0.24
50.33%
-1.34
466.65%
-1.42
5.69%
-0.00
99.92%
payables turnover
2.16
-
3.26
50.56%
0.89
72.62%
1.16
29.92%
3.42
195.43%
receivables turnover
3.21
-
6.56
104.51%
5.82
11.36%
7.69
32.32%
5.69
26.10%
research and ddevelopement to revenue
0.21
-
0.23
9.08%
0.29
26.36%
0.31
8.45%
0.23
26.94%
return on tangible assets
-0.31
-
-0.46
45.14%
-0.28
37.77%
-0.51
80.99%
-0.44
14.68%
revenue per share
1.46
-
1.47
0.49%
2.04
39.10%
1.98
2.87%
0.00
99.89%
roe
0.49
-
-0.90
283.92%
-0.35
60.67%
-1.21
240.83%
-1.18
2.34%
roic
2.67
-
-0.21
107.98%
-0.24
12.60%
-0.45
88.11%
-0.38
14.88%
sales general and administrative to revenue
shareholders equity per share
-1.04
-
0.64
161.58%
4.51
602.50%
1.55
65.60%
0.00
99.92%
stock based compensation to revenue
0.00
-
0.01
210.24%
0.07
554.42%
0.10
34.95%
0.11
8.82%
tangible asset value
-72.56M
-
-22.41M
69.12%
81.94M
465.72%
20.27M
75.26%
18.10M
10.73%
tangible book value per share
-2.51
-
-0.77
69.12%
3.05
493.17%
0.54
82.37%
0.00
99.92%
working capital
19.72M
-
11.53M
41.51%
113.13M
880.86%
75.14M
33.58%
86.44M
15.04%

All numbers in USD (except ratios and percentages)